Cubist Systematic Strategies’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-119,985	Closed	-$881K	–	3577
2024 Q4	$881K	Sell	119,985 -54,755	-31%	-$432K	0.01%	1872
2024 Q3	$1.31M	Sell	174,740 -13,884	-7%	-$121K	0.01%	1669
2024 Q2	$1.68M	Buy	188,624 +185,723	+6,402%	+$1.78M	0.01%	1445
2024 Q1	$29.4K	Sell	2,901 -210,288	-99%	-$2.14M	﹤0.01%	3445
2023 Q4	$2.14M	Buy	213,189 +76,242	+56%	+$697K	0.01%	1456
2023 Q3	$1.28M	Buy	+136,947	New	+$1.95M	0.01%	1693
2023 Q2	–	Sell	-12,815	Closed	-$298K	–	4352
2023 Q1	$298K	Sell	12,815 -6,642	-34%	-$170K	﹤0.01%	3000
2022 Q4	$492K	Sell	19,457 -86,050	-82%	-$2.11M	﹤0.01%	3035
2022 Q3	$2.03M	Sell	105,507 -60,434	-36%	-$1.54M	0.01%	1997
2022 Q2	$4.23M	Buy	165,941 +5,438	+3%	+$127K	0.03%	1143
2022 Q1	$4.13M	Buy	160,503 +69,604	+77%	+$2.06M	0.03%	877
2021 Q4	$3.81M	Buy	90,899 +85,035	+1,450%	+$3.33M	0.04%	844
2021 Q3	$255K	Sell	5,864 -25,842	-82%	-$1.12M	﹤0.01%	2448
2021 Q2	$1.5M	Buy	31,706 +15,605	+97%	+$709K	0.02%	1286
2021 Q1	$825K	Buy	+16,101	New	+$868K	0.01%	1655